YD Bio YDES
NASDAQ YDES
$6.12 +0.20 (+3.38%)
At close: Oct 19, 2026 · 4:00 PM EDT

YD Bio (YDES) Current Leases (2024 - 2026)

Updated

Analysis

YD Bio (YDES) Current Leases (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn -
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn -
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn -
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn -
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn -
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn -
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn -
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn -
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn -
10 YD Bio 417.66 Mn 405.39 Mn - 5,002.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5,002.00
Dec 31, 2025 6,764.00
Jun 30, 2025 15,767.00
Dec 31, 2024 16,581.00
API Access

YD Bio Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=YDES&period=max&api_key=YOUR_API_KEY